QUANTEXA RECOGNIZED AS A "LUMINARY" IN CELENT'S 2024 INSURANCE FRAUD DETECTION SOLUTIONS REPORT
QUANTEXA RECOGNIZED AS A "LUMINARY" IN CELENT'S 2024 INSURANCE FRAUD DETECTION SOLUTIONS REPORT Thursday 05/09/2024 Fraud and Security...
AI-MEDIA TO UNVEIL ALTA PLATFORM GROUNDBREAKING INNOVATIONS AT IBC 2024
KUALA LUMPUR, Sept 6 (Bernama) -- AI-Media, the leader in live video captioning and subtitling solutions, is set to unveil a suite of...
NIPPON KINZOKU EXHIBITS AT "STAINLESS STEEL WORLD ASIA 2024"
TOKYO, Sept 4 (Bernama-BUSINESS WIRE) -- NIPPON KINZOKU CO., LTD. (TOKYO: 5491, Headquarters: Minato-ku, Tokyo) and Tokyo Stainless...
OLON ACQUIRES HUVEPHARMA ITALIA TO INCREASE API PRODUCTION CAPACITY
KUALA LUMPUR, Sept 5 (Bernama) -- Olon, the chemical-pharmaceutical group in the production and development of active pharmaceutical...
3FORGE SECURES FUNDING FROM MORGAN STANLEY
KUALA LUMPUR, Sept 4 (Bernama) -- 3forge, leader in innovative High Impact code solutions for business-critical applications, announced...
AM BEST PUBLISHES ANNUAL REVIEW OF GLOBAL REINSURANCE INDUSTRY; ANALYSIS HIGHLIGHTS COMPANIES' FAVORABLE RESULTS, FINANCIAL REPORTING SHIFTS
OLDWICK, N.J., Sept 4 (Bernama-BUSINESS WIRE) -- As reinsurance industry leaders prepare to gather in Monte Carlo for the annual...
"EVERYONE'S MUSHROOM GARDEN" ENGLISH VERSION AVAILABLE ON IOS, ANDROID
KUALA LUMPUR, Sept 5 (Bernama) -- Tokyo-based mobile game developer, Beeworks Games has released the English version of "Everyone's...
TOSHIBA BEGINS SAMPLING OF AUTOMOTIVE CXPI RESPONDER INTERFACE IC
Toshiba: TB9033FTG, an automotive Clock Extension Peripheral Interface (CXPI) responder interface IC. (Graphic: Business Wire) KUALA...
AM BEST TO PARTICIPATE IN PANEL DISCUSSION AT EAST ASIAN INSURANCE CONGRESS 2024
HONG KONG, Sept 2 (Bernama-BUSINESS WIRE) -- AM Best will participate in a customer centric panel discussion at the 30th East Asian...
HENDRIK SCHOLL JOINS BELITE BIO AS CHIEF MEDICAL OFFICER
KUALA LUMPUR, Sept 2 (Bernama) -- Belite Bio Inc (Belite Bio), a clinical-stage biopharmaceutical drug development company, announced its...
